Suppliers and packages for generic ingredient: SELPERCATINIB
✉ Email this page to a colleague
SELPERCATINIB
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246 | NDA | Eli Lilly and Company | 0002-2980-26 | 120 CAPSULE in 1 BOTTLE (0002-2980-26) | 2020-05-08 |
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246 | NDA | Eli Lilly and Company | 0002-2980-60 | 60 CAPSULE in 1 BOTTLE (0002-2980-60) | 2020-05-08 |
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | CAPSULE;ORAL | 213246 | NDA | Eli Lilly and Company | 0002-3977-60 | 60 CAPSULE in 1 BOTTLE (0002-3977-60) | 2020-05-08 |
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | TABLET;ORAL | 218160 | NDA | Eli Lilly and Company | 0002-5340-60 | 60 TABLET, COATED in 1 BOTTLE (0002-5340-60) | 2024-04-10 |
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | TABLET;ORAL | 218160 | NDA | Eli Lilly and Company | 0002-5562-60 | 60 TABLET, COATED in 1 BOTTLE (0002-5562-60) | 2024-04-10 |
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | TABLET;ORAL | 218160 | NDA | Eli Lilly and Company | 0002-6082-60 | 60 TABLET, COATED in 1 BOTTLE (0002-6082-60) | 2024-04-10 |
| Loxo Oncol Eli Lilly | RETEVMO | selpercatinib | TABLET;ORAL | 218160 | NDA | Eli Lilly and Company | 0002-6120-60 | 60 TABLET, COATED in 1 BOTTLE (0002-6120-60) | 2024-04-10 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
